Company / Capital Expenditures
Olema Pharmaceuticals, Inc. Capital Expenditures History
FY2020-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$159.0K
FY2024
5-year range
$56.0K / $1.6M
FY2020-FY2024
Trend
-
vs FY2023
Sector context
#165 of 194
Health Care
What the data says
Olema Pharmaceuticals, Inc.'s capital expenditures of $159,000 is lower than 85% of companies in the Health Care sector (FY2024). Declined from $2M to $159,000 over the past 3 years.
Based on SEC 10-K filings.
$159,000 in FY2024 with a 3-year CAGR of -53.4%.
Declined from $2M to $159,000 over the past 3 years.
Health Care sector context is included.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- -53.4%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 15% in Health CareTop 85% of 194This company $159.0K Sector average $117.5M
▼
-99.9% below sector average
Key checks
Key Insights
- 3-year CAGR of -53.4%, indicating a declining trend.
- Ranks #165 out of 194 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 3.74 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $159.0K | - |
| FY2023 | - | - |
| FY2022 | $363.0K | -77.0% |
| FY2021 | $1.6M | +2712.5% |
| FY2020 | $56.0K | - |
| FY2019 | - | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026